MEI Pharma
MEIP
MEIP
52 hedge funds and large institutions have $12.1M invested in MEI Pharma in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 17 closing their positions.
Holders
52
Holders Change
-10
Holders Change %
-16.13%
% of All Funds
0.84%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
7
Increased
11
Reduced
14
Closed
17
Calls
$52K
Puts
$1K
Net Calls
+$51K
Net Calls Change
-$257K
Top Buyers
1 |
AFM
1
Anson Funds Management
Dallas,
Texas
|
$2.59M |
2 |
2
Acadian Asset Management
Boston,
Massachusetts
|
$1.16M |
3 |
3
Morgan Stanley
New York
|
$45.1K |
4 |
4
UBS Group
Zurich,
Switzerland
|
$31.8K |
5 |
5
Prudential Financial
Newark,
New Jersey
|
$35.7K |